A practical reference on evidence base: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-08-18 and is reviewed periodically as new material appears.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilised material; shade varies slightly between lots |
| Solubility in water | Freely soluble | Dissolves in water, saline, and aqueous buffers |
| Solubility in nonpolar solvents | Poorly soluble | Not compatible with oils or hydrocarbon solvents |
| Typical storage temperature | About −20 °C | Lyophilised, dry, dark storage slows hydrolysis |
| Common purity method | Reversed-phase HPLC | Area percentage, usually paired with mass spectrometry |
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
==== HCG Pubergen, Pregnyl warnings ==== In the case of female patients who want to be treated with HCG Pubergen, Pregnyl: a) Since infertile female patients who undergo medically assisted reproduction (especially those who need in vitro fertilization), are known to often be suffering from tubal abnormalities, after a treatment with this drug they might experience many more ectopic pregnancies. This is why early ultrasound confirmation at the beginning of a pregnancy (to see whether the pregnancy is intrauterine or not) is crucial. Pregnancies that have occurred after a treatment with this drug have a higher risk of multiple pregnancy. Female patients who have thrombosis, severe obesity, or thrombophilia should not be prescribed this medicine as they have a higher risk of arterial or venous thromboembolic events after or during a treatment with HCG Pubergen, Pregnyl. b)Female patients who have been treated with this medicine are usually more prone to pregnancy losses. In the case of male patients: A prolonged treatment with HCG Pubergen, Pregnyl is known to regularly lead to increased production of androgen. Therefore: Patients who have overt or latent cardiac failure, hypertension, renal dysfunction, migraines, or epilepsy might not be allowed to start using this medicine or may require a lower dose of HCG Pubergen, Pregnyl. This drug should be used with extreme caution in the treatment of prepubescent teenagers in order to reduce the risk of precocious sexual development or premature epiphyseal closure.
== See also == C-terminal telopeptide, commonly known as CTX, a serum biomarker for bone turnover rate and a tool used to evaluate patient risk for complications due to BRONJ Osteonecrosis of the jaw, see section on Bisphosphonates Osteoradionecrosis, a term for osteonecrosis caused by radiotherapy Phossy jaw
Haemovigilance – incident management, investigation, follow-up, and reporting Risk management including writing, implementing, updating and monitoring local policies and procedures Blood management education Monitoring and providing feedback on activities related to compliance with best practice guidelines including auditing Change management activities Appropriate use and management including waste minimisation Assisting with the implementation of PBM strategies
=== Multi-parametric surface plasmon resonance === Multi-parametric surface plasmon resonance has been utilized to characterize both the thickness and refractive index of chemical-vapor-deposition (CVD)-grown graphene films. At a wavelength of 670 nm (6.7×10−7 m), measured refractive index and extinction coefficient values are 3.135 and 0.897, respectively. Thickness determination yielded 3.7 Å across a 0.5mm area, consistent with the 3.35 Å reported for layer-to-layer carbon atom distance of graphite crystals. This method is applicable for real-time label-free interactions of graphene with organic and inorganic substances. The existence of unidirectional surface plasmons in nonreciprocal graphene-based gyrotropic interfaces has been theoretically demonstrated, offering tunability from THz to near-infrared and visible frequencies by controlling graphene's chemical potential. Particularly, the unidirectional frequency bandwidth can be 1– 2 orders of magnitude larger than that achievable with metal under similar magnetic field conditions, stemming from graphene's extremely small effective electron mass.
Schwartz Award (for Significant Contributions in Cancer Research Diagnostics American Association for Clinical Chemistry) 2015–Present: Wittliff Lecture Series at San Marcos Academy honoring his career contributions 2021 John G. Tower Distinguished Alumni Award, Texas Tech University, Kappa Sigma Fraternity
Sources: en.wikipedia.org
== Inorganic analysis == In 1983 a paper was published describing the use of fast atom bombardment mass spectrometry (FAB-MS) to analyze isotopes of calcium. Glycerol was not used; samples in aqueous solution were deposited on the sample target and dried prior to analysis. The technique was effectively secondary ion mass spectrometry using a neutral primary beam. This was a welcomed development for biomedical researchers studying the nutrition and metabolism of essential minerals but lacking access to inorganic mass spectrometry instrumentation such as thermal ionization mass spectrometry or inductively-coupled plasma mass spectrometry (ICP-MS). In contrast, FAB mass spectrometers were widely found in biomedical research institutions. Multiple laboratories adopted this technique, using FAB-MS to measure isotope ratios in isotope tracer studies of calcium, iron, magnesium and zinc. The analysis of metals required minimal modification of the mass spectrometers, e.g.replacing the stainless steel sample targets with pure silver ones to eliminate background from ionization of stainless steel components. Signal acquisition systems were sometimes modified to perform peak jumping instead of scanning and to do ion counting detection. While satisfactory precision and accuracy were attained with FAB-MS, the technique was labor-intensive with a very low sample through-put rate due in part to the absence of auto-sampling options.
== Network == Today, the IIR has 59 member countries representing over two-thirds of the global population. According to their annual financial contributions to the IIR, these member countries are divided into six categories, and this determines the services they receive and their level of voting power within the IIR. Member countries take part in IIR activities via their delegates and their nominated commission members. The delegates and commission members determine IIR priorities and take part in the IIR scientific activities and working groups, and develop recommendations. Member countries are entitled to host several IIR conferences and meetings per year.
Kilishi – a version of biltong or jerky that originated in Hausaland, it is a delicacy made from cow, sheep or goat meat after the removal of bone. Kuivaliha – salted and dried meat, often reindeer meat, is a traditional food and a delicacy of northern Finland, prepared at springtime. Kulen – a kind of highly spiced, semi-dried, smoked, cured sausage from Croatia (Slavonia) and Serbia (Vojvodina). The meat undergoes fermentation-curing as well as the air-drying.
Singapore and Malaysia: Woodlands Train Checkpoint (Malay: Pusat Pemeriksaan Kereta Api Woodlands, Chinese: 兀兰火车关卡, Tamil: ஊட்லண்ட்ஸ் இரயில் மசாதலைச்சாவடிப): For cross-border rail passengers, Singaporean exit and Malaysian entry preclearance border controls are co-located at the Woodlands Train Checkpoint in Singapore, whilst Malaysian exit controls are located separately at Johor Bahru Sentral railway station in Malaysia. Johor Bahru – Singapore Rapid Transit System (Malay: Sistem Transit Aliran Johor Bahru–Singapura, Chinese: 新山－新加坡捷运系统, Tamil: ஜோகூர் பாரு – சிங்கப்பூர் விரைவான போக்குவரத்து அமைப்பு, RTS): The upcoming RTS connecting Singapore and Johor Bahru will feature border control preclearance both on the Singaporean side and on the Malaysian side. This will enable passengers arriving in Singapore from Malaysia or vice versa to proceed straight to their connecting transport, since the RTS will link to both the Singapore MRT system (Thomson–East Coast Line) and Johor Bahru Sentral. Unlike the preclearance systems adopted in America and Hong Kong, but similar to the United Kingdom's juxtaposed controls, this system will mitigate the need for arrival border controls on both sides of the border. Malaysia and Thailand: Padang Besar railway station (Thai: สถานีรถไฟปาดังเบซาร์, Malay: Stesen keretapi Padang Besar): The Padang Besar railway station in Padang Besar, Malaysia has co-located border control facilities for both Malaysia and Thailand. However, the station is entirely within Malaysian territory (albeit just 200 metres south of the Malaysia-Thailand border).
position effect Any effect on the expression or functionality of a gene or sequence that is a consequence of its location or position within a chromosome or other DNA molecule. A sequence's precise location relative to other sequences and structures tends to strongly influence its activity and other properties, because different loci on the same molecule can have substantially different genetic backgrounds and physical/chemical environments, which may also change over time. For example, the transcription of a gene located very close to a nucleosome, centromere, or telomere is often repressed or entirely prevented because the proteins that make up these structures block access to the DNA by transcription factors, while the same gene is transcribed at a much higher rate when located in euchromatin. Proximity to promoters, enhancers, and other regulatory elements, as well as to regions of frequent transposition by mobile elements, can also directly affect expression; being located near the end of a chromosomal arm or to common crossover points may affect when replication occurs and the likelihood of recombination. Position effects are a major focus of research in the field of epigenetics.
Sources: en.wikipedia.org
Lyophilised peptide powders are generally kept frozen or refrigerated, dry, and protected from light. Sealed vials limit moisture uptake and slow hydrolysis. Such guidance comes from general peptide chemistry rather than from stability studies specific to every product.
Reversed-phase HPLC is the standard approach, with purity expressed as a percentage of total peak area. Mass spectrometry confirms the expected molecular mass and can reveal adducts or truncated sequences. Neither method on its own establishes biological activity.
Small mass differences often reflect different counterions, such as acetate versus trifluoroacetate, or bound water rather than a different amino acid sequence. Mass spectrometry can distinguish these forms when the ionisation conditions are known. Exact sequence confirmation requires peptide mapping or tandem mass spectrometry.
It is a synthetic fifteen-amino-acid peptide whose sequence matches part of a protein found in human gastric juice. It is made by chemical synthesis, not purified from tissue. The name derives from an early fragment label, not from a molecular weight.